4//SEC Filing
RYAN STEPHEN J 4
Accession 0001127602-13-002029
CIK 0000850693other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 5:47 PM ET
Size
9.2 KB
Accession
0001127602-13-002029
Insider Transaction Report
Form 4
ALLERGAN INCAGN
RYAN STEPHEN J
Director
Transactions
- Exercise/Conversion
Common Stock
2013-01-15$60.60/sh+5,700$345,420→ 10,969.752 total - Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2013-01-15−5,700→ 5,700 totalExercise: $60.60Exp: 2017-05-01→ Common Stock (5,700 underlying) - Sale
Common Stock
2013-01-15$103.30/sh−5,700$588,810→ 5,269.752 total
Holdings
- 42,613(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2012.
- [F2]Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
- [F3]S & A Ryan Living 1994 Trust, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
- [F4]Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeother
Related Parties
1- filerCIK 0001190632
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 5:47 PM ET
- Size
- 9.2 KB